Oh, and one more thing:
They will show as having no or little income at this stage because THEY HAVE NOTHING TO SELL! Without grants or financing by big pharma, at this stage, dilution is a must to (though I hate it) to continue research and pay for operations.
So, quarterly will probably be ugly. Is that a surprise? Shouldn't be. They are getting ready to begin trials for a drug that is not yet available. When, however, the trials are successful (or at least showing some promise), then that is when funds will come in (if not before).
Please enlighten yourselves on how this works. WE ALL START OUT SMALL.
RESEARCH BMSN and stay LONG!
